INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
Report Outlook
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 16.38 Billion by 2029 | 8.97% | North America |
| By Product | By Process | By End-User | By Region |
|---|---|---|---|
|
|
|
|
SCOPE OF THE REPORT
Cell Analysis Market Overview
The Cell Analysis Market is expected to grow at 8.97% CAGR from 2023 to 2029. It is expected to reach above USD 16.38 Billion by 2029 from USD 1.9 Billion in 2022.
Cellular analysis is used to assess and quantify cell number, cell state, cell health and viability, proliferation, and toxicity caused by chemicals and cells. Basic research, drug discovery and development, and clinical applications all benefit from cell-based assays. Cellular analysis employs a wide range of assays and techniques. Cellular assays, also known as cell-based assays, are important tools for determining cell health, viability, proliferation, migration, invasion, chemotaxis, apoptosis, angiogenesis, oxidative stress, cell signaling, and live cell analysis.
Cell analysis is used in academic and research laboratories, hospitals, biotechnology and pharmaceutical companies, and to study stem cells, immunology, neurology, non-invasive prenatal diagnosis, and in-vitro fertilization. Furthermore, the rising prevalence of chronic diseases, as well as the development of advanced cancer therapies, are spurring technological advancements in cell analysis.
Increased government investments in extensive research and development (R&D) activities in the life sciences sector are another major growth-inducing factor. Other factors, such as the rapid expansion of biopharmaceutical and biotechnological companies, as well as significant growth in the healthcare industry, are expected to contribute to the market’s positive outlook.
The expansion of the healthcare sector and the rise in cancer incidence are the main drivers of the market for cell analysis. Additionally, the growth of hospitals, diagnostic labs, and other facilities as well as the introduction of technologically sophisticated items all contribute to the market’s expansion. However, the high cost of the cell analysis technique and the labor-intensive and complicated regulatory rules restrain market expansion. Growth prospects for the market are anticipated to be provided by an increase in government funding in the life sciences industry and the rapid expansion of the biopharmaceutical & biotechnological industries.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion) |
| Segmentation | By Platform, By Charging type, By Charging Method, By Region |
| By Product
 |
|
| By Process
 |
|
| By End-user
 |
|
| By Region
 |
|
High-throughput equipment has been developed as a result of the funding for creative research and the growing demand for analytical instruments. This technology now includes features like automation, high sensitivity, and precision, all of which help with the analysis of sparse samples. This is the result of numerous improvements.
Cell analysis technology is advancing due to the increased incidence of chronic diseases and the creation of cutting-edge cancer medicines. For instance, the American company Fluidigm Corporation recently announced the release of their REAP-seq (RNA expression and protein sequencing) technology, which will help researchers better comprehend the mechanisms underlying immune response and cancer progression.
Instrument costs have gone up due to high content screening (HCS), one of the advanced cell analysis technologies. The price and duration of any HTS approach are also directly influenced by the complexity of the targeted molecule. Therefore, only a small number of end users can access novel cell analysis solutions. But certain obstacles are somewhat limiting the market’s expansion for cell analysis. These include stringent legal specifications, a shortage of qualified professionals, and expensive image analysis tools.
The cost of installing the necessary equipment to carry out the process is somewhat prohibitive to the growth of the global cell analysis market. Lack of standardization may also quietly degrade market demand. The entry of new players, as well as increased competition among them, is a challenging factor for market developers. Strict rules and regulations for approving new products are impeding market demand.
The sudden outbreak of the COVID-19 pandemic has increased the use of cell analysis technology in a variety of research procedures for developing effective vaccines, drugs, and testing kits to combat the risk of coronavirus infection. The ongoing COVID-19 pandemic has benefited the single-cell analysis market (SCA). The pandemic has prompted widespread use of SCA methods in virology research. Researchers are analyzing specimens from COVID-19 biobanks to better understand the immune response and long-term effects of infections in order to better understand the profiles of infected patients.
Cell Analysis Market Segment Analysis
The Cell Analysis Market is segmented based on product, process, end-user and region, global trends and forecast.
By Product market is segmented into Flow Cytometry Products, qPCR Products, Cell Microarrays, Microscopes, Spectrophotometers, Cell Counters, HCS Systems, and Others; by Process market is segmented into Cell Identification, Cell Viability, Cell Signaling Pathways/Signal Transduction, Cell Proliferation, Cell Counting and Quality Control, Cell Interaction, Target Identification and Validation, Single-Cell Analysis, Others; by End-user market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Research Institutes, Cell Culture Collection Repositories, and Others.
In 2021, flow cytometry had the largest market share, by product. Due to flow cytometry’s widespread use in single-cell analysis applications and its capacity to evaluate a variety of characteristics in heterogeneous samples at the single-cell level, this segment accounts for a sizeable portion of the market. In contrast, it is anticipated that the high-content screening category will expand at the quickest rate during the course of the projected period. The number of studies on cell behavior is rising, which is why the market is expanding. However, the difficulties with fluorescent lighting-related procedures for cell image collecting and analysis may limit the segment’s capacity for generating income to some extent.
By Process, Cell identification had the most market share in 2021. A critical stage in numerous industrial applications, including those in the food and healthcare industries, is cell identification. Because cells are recognized based on how they respond to a particular chemical, cell identification is crucial in the drug discovery process. The single-cell analysis market is anticipated to expand at the quickest rate during the course of the projection. The segment has grown significantly in recent years thanks to single-cell analysis, which evaluates individual cells at a multi-parametric level.
By the end user, due to the widespread adoption of single-cell analysis technology in research settings, the academic and research laboratories accounted for the biggest revenue share of nearly 70.4% in 2021. The adoption of SCA has been delayed until 2021 due to the volume of ongoing scientific research using SCA methodology at numerous universities. The advancement of spatial genomics, which expedites single-cell analysis in research operations, is another significant driver boosting the sector. Additionally, in June 2022, scientists at Stony Brook University in New York created single-cell cyclic multiplex in situ tagging (CycMIST) technology, a brand-new biomedical research tool that is already dominating the market. This method helps with diagnostic and research efforts by enabling scientists to assess functional proteins in a single cell.
Cell Analysis Market Players
The Cell Analysis Market key players include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, Thermo Fisher Scientific, and others.
23 January 2023: The world’s top provider of diagnostic information services, Quest Diagnostics (NYSE: DGX), and Agilent Technologies Inc. (NYSE: A) today announced a partnership. The agreement will make the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test available to providers and patients across the United States.
03 February 2023: In order to run high-throughput studies without compromising sample integrity, scientists at D (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the development of a new instrument for single-cell multiomics analysis.
Who Should Buy? Or Key Stakeholders
- Research and development
- Manufacturing
- Diagnostic Centers and Hospitals
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Research and Academic Institutes
- Healthcare sector
- Specialty Clinic
- Others
Cell Analysis Market Regional Analysis
The Cell Analysis Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Russia, Spain, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes UAE, Egypt, Saudi Arabia, South Africa, and Rest of MEA
Due to its high cancer prevalence, extensive R&D, and technological breakthroughs in cell analysis systems, North America will dominate the global market for cell analysis in the years to come. The growth of the cell analysis market in North America is also being fueled by the presence of numerous hospitals, pharmaceutical and biotechnology businesses, and academic and research institutions. Businesses and research institutions in these areas have played a vital role in doing important research on stem cells and their potential to treat fatal diseases like cancer and multiple sclerosis.
Through the projection period, the Asia Pacific region is anticipated to experience considerable growth at a CAGR of 8.97%. The rapid expansion of the pharmaceutical and biopharmaceutical industries as well as the cost-effectiveness of cell analysis services are the main forces behind regional growth. Manufacturers and researchers are working together to create cutting-edge cell analysis technologies that will improve patient care. The Cell Analysis System Market is anticipated to be driven by manufacturers’ focus on growing their businesses in emerging nations.
Key Market Segments: Cell Analysis Market
Cell Analysis Market By Product, 2020-2029, (USD Billion)
- Flow Cytometry Products
- QPCR Products
- Cell Microarrays
- Microscopes
- Spectrophotometers
- Cell Counters
- HCS Systems
- Others
Cell Analysis Market By Process, 2020-2029, (USD Billion)
- Cell Identification
- Cell Viability
- Cell Signaling Pathways/Signal Transduction
- Cell Proliferation
- Cell Counting And Quality Control
- Cell Interaction
- Target Identification And Validation
- Single-Cell Analysis
- Others
Cell Analysis Market By End-User, 2020-2029, (USD Billion)
- Pharmaceutical & Biotechnology Companies
- Hospitals And Clinical Testing Laboratories
- Academic And Research Institutes
- Other End Users
Cell Analysis Market By Region, 2020-2029, (USD Billion)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the Cell analysis market over the next 5 years?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the Cell analysis market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the Cell analysis market?
- What is the current and forecasted size and growth rate of the global Cell analysis market?
- What are the key drivers of growth in the Cell analysis market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the Cell analysis market?
- What are the technological advancements and innovations in the Cell analysis market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the Cell analysis market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the Cell analysis market?
- What are the service offerings and specifications of leading players in the market?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global cell analysis market outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 on cell analysis market
- Porter’s five forces model
- Threat from new entrants
- Threat from substitutes
- Bargaining power of suppliers
- Bargaining power of customers
- Degree of competition
- Industry value chain Analysis
- Global cell analysis market outlook
- GLOBAL CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
- Flow cytometry products
- qPCR products
- Cell microarrays
- Microscopes
- Spectrophotometers
- Cell counters
- HCS systems
- Others
- GLOBAL CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
- Cell identification
- Cell viability
- Cell signaling pathways/signal transduction
- Cell proliferation
- Cell counting and quality control
- Cell interaction
- Target identification and validation
- Single-cell analysis
- Others
- GLOBAL CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
- Pharmaceutical & biotechnology companies
- Hospitals and clinical testing laboratories
- Academic and research institutes
- Other end users
- GLOBAL CELL ANALYSIS MARKET BY REGION (USD BILLION), 2020-2029
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest Of South America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- Rest Of Asia Pacific
- Middle East and Africa
- UAE
- Egypt
- Saudi Arabia
- South Africa
- Rest Of Middle East and Africa
- North America
- Company Profiles*
(Business Overview, Company Snapshot, Products Offered, Recent Developments)
- Agilent Technologies Inc.
- BD Biosciences
- Bio-RAD Laboratories Inc.
- Danaher Corporation
- Illumina Inc.
- Merck KGaA
- Miltenyi Biotec
- Olympus Corporation
- PerkinElmer Inc.
- Promega Corporation
- Sysmex Corporation
- Thermo Fisher Scientific
*The Company List Is Indicative
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â GLOBAL CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â GLOBAL CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â GLOBAL CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â GLOBAL CELL ANALYSIS MARKET BY REGION (USD BILLION), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA CELL ANALYSIS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â US CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â US CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â US CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â CANADA CELL ANALYSIS MARKET BY PRODUCT (BILLION), 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â CANADA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â CANADA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â MEXICO CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â MEXICO CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â MEXICO CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â SOUTH AMERICA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â SOUTH AMERICA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â SOUTH AMERICA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â SOUTH AMERICA CELL ANALYSIS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â BRAZIL CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â BRAZIL CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â BRAZIL CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â ARGENTINA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â ARGENTINA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â ARGENTINA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â COLOMBIA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â COLOMBIA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â COLOMBIA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â ASIA-PACIFIC CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â ASIA-PACIFIC CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â ASIA-PACIFIC CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â ASIA-PACIFIC CELL ANALYSIS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â INDIA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â INDIA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â INDIA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â CHINA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â CHINA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â CHINA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â JAPAN CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â JAPAN CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â JAPAN CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â SOUTH KOREA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â SOUTH KOREA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â SOUTH KOREA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â AUSTRALIA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â AUSTRALIA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â AUSTRALIA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â EUROPE CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â EUROPE CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â EUROPE CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â EUROPE CELL ANALYSIS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â GERMANY CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â GERMANY CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â GERMANY CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â UK CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â UK CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â UK CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â FRANCE CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â FRANCE CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â FRANCE CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â ITALY CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â ITALY CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â ITALY CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â SPAIN CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â SPAIN CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â SPAIN CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â RUSSIA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â RUSSIA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â RUSSIA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â REST OF EUROPE CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â REST OF EUROPE CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â REST OF EUROPE CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â UAE CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â UAE CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â UAE CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â SAUDI ARABIA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â SAUDI ARABIA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â SAUDI ARABIA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â SOUTH AFRICA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â SOUTH AFRICA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â SOUTH AFRICA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â EGYPT CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â EGYPT CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â EGYPT CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY PROCESS (USD BILLION), 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA CELL ANALYSIS MARKET BY END-USER (USD BILLION), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â GLOBAL CELL ANALYSIS MARKET BY PRODUCT, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â GLOBAL CELL ANALYSIS MARKET BY PROCESS, USD BILLION, 2020-2029
FIGURE 10Â Â GLOBAL CELL ANALYSIS MARKET BY END-USER, USD BILLION, 2020-2029
FIGURE 11Â Â GLOBAL CELL ANALYSIS MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 12  PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â GLOBAL CELL ANALYSIS MARKET BY REGION 2021
FIGURE 14Â Â GLOBAL CELL ANALYSIS MARKET BY PRODUCT 2021
FIGURE 15Â Â GLOBAL CELL ANALYSIS MARKET BY PROCESS 2021
FIGURE 16Â Â GLOBAL CELL ANALYSIS MARKET BY END-USER 2021
FIGURE 17Â Â MARKET SHARE ANALYSIS
FIGURE 18Â Â AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
FIGURE 19Â Â BD BIOSCIENCES: COMPANY SNAPSHOT
FIGURE 20Â Â BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
FIGURE 21Â Â DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 22Â Â ILLUMINA INC.: COMPANY SNAPSHOT
FIGURE 23Â Â MERCK KGAA: COMPANY SNAPSHOT
FIGURE 24Â Â MILTENYI BIOTEC: COMPANY SNAPSHOT
FIGURE 25Â Â OLYMPUS CORPORATION: COMPANY SNAPSHOT
FIGURE 26Â Â PERKINELMER INC.: COMPANY SNAPSHOT
FIGURE 27Â Â PROMEGA CORPORATION: COMPANY SNAPSHOT
FIGURE 28Â Â SYSMEX CORPORATION: COMPANY SNAPSHOT
FIGURE 29Â Â THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FAQ
Cell Analysis Market was valued at USD 17.4 Billion in 2021 and is projected to reach USD 34.96 Billion by 2029, growing at a CAGR of 8.97% from 2022 to 2029.
Key market players include Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, Thermo Fisher Scientific, and others.
The sudden outbreak of the COVID-19 pandemic has led to the adoption of cell analysis technology in research procedures for developing effective vaccines, drugs, and testing kits to combat the risk of coronavirus infection.
Based On the region, the market has been classified into North America, Europe, Asia Pacific, Middle, East and Africa, and Latin America. North America dominates the global market.
The extensive utilization of cell analysis technology across hospitals and medical research laboratories pertaining to immunology, neurology, non-invasive prenatal diagnosis, in-vitro fertilization, etc., is primarily driving the global cell analysis market.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.